PATH/Matt Steele
GHTC sends letter of support for House PAHPA bill

GHTC sent a letter to members of the House of Representatives in support of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 (H.R. 6378) (PAHPA), commending the inclusion of specific provisions and dedicated funding to advance the development of medical countermeasures to address emerging infectious diseases and pandemic influenza.


PATH/Aaron Joel Santos
GHTC launches petition calling on world leaders to include R&D in the Global Health Security Agenda

GHTC launched a new online petition calling on world leaders to include clear commitments to strengthening R&D capacity in the 2019-2024 Global Health Security Agenda framework, which is currently under development.


PATH/Nguyen Ba Quang
GHTC sends letter urging House leaders to bolster BARDA’s authority and resources to combat naturally occurring health threats

GHTC sent a letter to the Chairman and Ranking Member of the House Energy and Commerce Committee encouraging them, through the reauthorization of the Pandemics and All-Hazards Preparedness Act, to ensure the Biomedical Advanced Research and Development Authority (BARDA) has ample resources and authority to address emerging infectious diseases (EIDs), pandemic influenza (PI), and antimicrobial resistance (AMR). The letter specifically calls for the creation of a separate funding line of $300 million for EIDS at BARDA, formalization of BARDA’s AMR workstream, and new reporting requirements on the agency’s work in EIDS, PI, and AMR.


Flickr/Craig Fildes
GHTC submits FY19 testimony to Senate appropriators

GHTC submitted written testimony to key Senate appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2019 (FY19) budget. 

Learn More

All News


Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide